Evaluation of Asymptomatic Coronary Atherosclerotic Disease Among People of Kalamazoo, MI
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Vishal Gupta, MD, MPH
Borgess Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Borgess Medical Center
Kalamazoo, Michigan, United States
Anna Langerveld, PhDAzzam Kannan, MDJames Springstead, PhDJesse Duranceau, MDJohn Hopkins, MDMarcio Curvello, MDMark Shaman, MDRonald Zegerius, MDVishal Gupta, MD, MPHRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2016
- Primary completion
- 31 Jan 2022
- Completion
- 31 Mar 2022
- Last update posted
- 1 Sept 2020
- Registered enrollment
- 240
- Registry id
- NCT02942342
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.